Gheorghe Doros
-
- Hormonal and reproductive studies 30
- Internal Medicine top 1%
-
- Cardiac, Anesthesia and Surgical Outcomes 35
- Pulmonary and Respiratory Medicine top 0.5%
- Vascular Procedures and Complications 37
- Aortic aneurysm repair treatments 36
- Cerebrovascular and Carotid Artery Diseases 23
- Nephrology top 1%
-
- Peripheral Artery Disease Management 41
- Coronary Interventions and Diagnostics 23
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 35
Gheorghe Doros
278 papers receiving 9.4k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Endocrinology, Diabetes and Metabolism 1.6k
- Internal Medicine 314
- Cardiology and Cardiovascular Medicine 1.9k
- Pulmonary and Respiratory Medicine 2.4k
- Nephrology 466
Countries citing papers authored by Gheorghe Doros
This map shows the geographic impact of Gheorghe Doros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gheorghe Doros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gheorghe Doros more than expected).
Fields of papers citing papers by Gheorghe Doros
This network shows the impact of papers produced by Gheorghe Doros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gheorghe Doros. The network helps show where Gheorghe Doros may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gheorghe Doros, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 9 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 4 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 42 | |
| 10 | 2019 | 3 | |
| 11 | Abstract 13123: Diflunisal is Associated With Improved Mortality in Patients With Wild-Type ATTR Cardiac Amyloidosis: The BU Amyloidosis Center Experience | 2019 | 2 |
| 12 | 2018 | 2 | |
| 13 | Abstract 14202: The Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation (BOAT-AF) Study: A Prospective, Multicenter Study Evaluating Perspectives on Use of Oral Anticoagulation Using a Patient Survey and Clinical Review by the Treating Physician Among Patients Not Currently Treated With Oral Anticoagulation | 2018 | 1 |
| 14 | N-Terminal Pro–B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study | 2018 | 5 |
| 15 | 2017 | 33 | |
| 16 | 2017 | 7 | |
| 17 | 2015 | 18 | |
| 18 | 2013 | 73 | |
| 19 | 2008 | 61 | |
| 20 | 2007 | 117 |
About Gheorghe Doros
Gheorghe Doros is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 289 papers that have together received 9.6k indexed citations. Recurring topics across this work include Peripheral Artery Disease Management (41 papers), Vascular Procedures and Complications (37 papers), Aortic aneurysm repair treatments (36 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (35 papers), Cardiac, Anesthesia and Surgical Outcomes (35 papers), Hormonal and reproductive studies (30 papers), Cerebrovascular and Carotid Artery Diseases (23 papers) and Coronary Interventions and Diagnostics (23 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Internal Medicine (314 citations) and Cardiology and Cardiovascular Medicine (1.9k citations). Gheorghe Doros has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Denis Rybin, Ahmad Haider, Farid Saad, Alik Farber, Oren K. Fix, Edwin J. Lai, Brian C. Jacobson, Audrey H. Calderwood, Aksam Yassin and Abdulmaged M. Traish. Their work appears in journals such as The Lancet, JAMA and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.